The expression of a gene, designated as Retroviral insertion site (Ris)2, was activated by retroviral DNA integration in an immortalized primitive erythroid cell line, EB-PE. Ris2 was also expressed at high levels in all human tumor cell lines analysed. Consistently, NIH3T3 ®broblasts overexpressing Ris2 formed tumors in Rag2
Introduction
The mammalian cell cycle, consisting of the G1 phase, S phase and G2/mitosis, is a highly ordered process that results in a faithful duplication of the genetic information. Each transition is tightly controlled by an array of regulatory proteins to ensure that DNA is replicated only once and divided equally to two daughter cells. Eukaryotic DNA replication is achieved by simultaneously ®ring-up thousands of origins of replication throughout the chromosomes. Six sub-units of the origin of recognition complex (ORC)1-6, (Bell and Stillman, 1992) , cell division cycle (CDC)-6 (Hartwell, 1976) , and mini-chromosome maintenance (MCM) proteins 2 ± 7 (Moir et al., 1982; Maine et al., 1984) are thought to assemble sequentially onto the origin of replication in order for DNA replication to be initiated (Quintana and Dutta, 1999; Fujita, 1999) . The state of DNA loaded with these proteins is called licensed'.
CDT1, originally isolated in ®ssion yeast as a target of the CDC10 transcription factor (Hofmann and Beach, 1994) , has recently been shown to be critical for the licensing process (Nishitani et al., 2000; Maiorano et al., 2000; Blow and Tada, 2000) . In ®ssion yeast, CDT1 cooperates with CDC18 (CDC6 in eukaryotes) to promote initiation of DNA replication. CDT1 and CDC18 can be co-immunoprecipitated from ®ssion yeast extracts (Nishitani et al., 2000) . In vitro DNA replication using Xenopus egg extracts demonstrated that Xenopus CDT1 (XCDT1) is required at the initiation step of DNA replication. XCDT1 has been shown to bind the ORC independently of CDC6, before the MCMs, and is destabilized from chromatin upon initiation of DNA synthesis (Maiorano et al., 2000) . The Drosophila homologue of CDT1, double parked (Dup), has also been shown to be essential for the initiation of DNA replication (Whittaker et al., 2000) . DUP co-localizes with ORC2 of the replication machinery. The dup mutants are also defective in DNA replication, both in embryogenesis and in oogenesis (Whittaker et al., 2000) .
Previously, we isolated an immortalized primitive erythroid cell line, EB-PE, using a retroviral insertional mutation (Yuen et al., 1998) . Here we show that the proviral DNA had integrated upstream of Cdt1 and activated the expression of Cdt1 in EB-PE cells. Retroviral DNA integration in eukaryotic cells has often led to the identi®cation of proto-oncogenes or tumor suppressor genes (Jonkers and Berns, 1996; Nusse and Varmus, 1982; Ben-David et al., 1991; Morishita et al., 1988) . In this study, we investigated whether CDT1 can function as an oncogene. We demonstrate that CDT1 is highly expressed in human tumor cell lines. We also show that NIH3T3 cells overexpressing Cdt1 can form tumors in mice. Furthermore, NIH3T3 cells constitutively overexpressing CDT1 entered S phase more readily than controls when released from serum starvation. Together, these data argue for a role of CDT1 in oncogenesis.
Results

Isolation of Ris2/Cdt1 cDNA
To characterize molecular events involved in the EB-PE immortalization, cellular DNA¯anking the retro-viral integration site was isolated by inverse polymerase chain reaction (PCR), using the restriction enzyme SphI and primers corresponding to sequences of the retroviral LTR and the neo gene ( Figure 1a) . A cellular 0.9 kb DNA (black), upstream of the retroviral DNA integration, and a 1.7 kb genomic DNA (grey), downstream of the pro-viral integration, were isolated and subsequently used on a Northern blot analysis to determine if any transcript was activated by retroviral insertion. A 1.2 kb transcript was readily detectable in EB-PE compared to control cells when the 0.9 kb upstream, but not 1.7 kb downstream,¯anking DNA was used as a probe (not shown). We designated this transcript as Retroviral insertion site 1 (Ris1). The Ris1 cDNA was subsequently used to isolate a bacterial arti®cial chromosome (BAC) clone from the 129 mouse strain to further analyse the retroviral insertion site (Figure 1b) . A 7.5 kb HindIII fragment of the BAC clone containing the Ris1 cDNA was subcloned into a plasmid vector pBS (Stratagene) and sequenced (submitted to Genbank). Sequence comparison of the Ris1 cDNA and HindIII fragment of the BAC clone indicated that the upstream sequence of the Ris1 gene within the HindIII fragment showed a high sequence similarity to mouse ESTs (Genbank accession numbers AI463912, AA545437, and AI265052), as well as human EST clones (Genbank accession numbers T80294 and BE018212) which have been shown to encode for CDT1 (Wohlschlegel et al., 2000) . The new mouse transcript was positioned head to head, going in the opposite direction of Ris1 transcription. We designated this second gene as Ris2/Cdt1 (Figure 1b) . The mouse and human EST clones corresponding to the Ris2/Cdt1 gene were subsequently obtained from Genome Systems and analysed. The full length mouse Ris2/Cdt1 cDNA was 2.2 kb with a predicted open RIS2 sequence similarity to Xenopus, Drosophila, and human CDT1
The putative mouse RIS2 protein is about 65 Kda in molecular weight, and is predicted to be a basic protein with a pI of 9.6. RIS2 contains two nuclear localization signals (NLS) and a coiled-coil domain (amino acids 128 ± 162), a region thought to interact with other proteins (Lupas et al., 1991) . Computational analysis of this coiled-coil region suggests that a trimeric coil will form (Wolf et al., 1997) . RIS2 also has a number of consensus phosphorylation sites. In addition, it contains a PEST sequence, a motif present within proteins with short half-lives (amino acids 68 ± 111, Rogers et al., 1986) . The mouse Ris2/Cdt1 gene product ( Figure 2 ) shows a strong similarity to Xenopus CDT1 (Genbank accession number AJ250122, 57% identity with a 72% positive substitution), as well as the Drosophila double parked gene (DUP, Genbank accession number AF279146, 29% identity with 45% positive substitution). As with Xenopus CDT1, mouse RIS2 or human CDT1 has a weak identity to yeast CDT1 (Genbank accession number Z27248). Mouse RIS2 and human CDT1 are highly conserved except within the N-terminal region ( Figure 2 ). All ®ve identi®ed CDT1 proteins contain putative NLS sequence and all but S pombe CDT1 have predicted PEST and coiled-coil regions. From the sequence analysis, we conclude that RIS.2 is most likely a mouse homologue of CDT1.
Activation of Ris2/Cdt1 in EB-PE cells and human tumor cells
Genomic mapping and data base searches show that the Aprt gene was located downstream of Ris2/Cdt1 (Figure 1 ). To determine if the retroviral integration could have activated the whole region, Northern blot analysis was performed using Ris1, Ris2/Cdt1 or Aprt cDNA as a probe. As shown, the expression of Ris1 and Ris2/Cdt1, but not Aprt, was up regulated in EB-PE cells (Figure 3a ) compared to control cells, including undierentiated ES cells, ES cells dierentiated for 6 days (day 6 EBs), primitive erythroid cells derived from day 4 EBs, and the D4T cell line generated by independent retroviral infection. We did not detect any transcript on Northern blot analyses when the downstream of the proviral integration 1.7 kb DNA was used as a probe, although EST clones corresponding to the 1.7 kb DNA exist. These results strongly suggested a correlation between the constitutive activation of Ris1 and/or Ris2/Cdt1 and the EB-PE immortalization phenotype. However, the full-length Ris1 cDNA, corresponding to 1.2 kb, did not contain any convincing open reading frames (ORFs). A total of ®ve short open reading frames, with a maximum length Figure 2 Amino acid sequence alignment. Mouse RIS2 protein sequence is compared to human, Xenopus CDT1, Drosophila DUP, and S Pombe CDT1. Predicted nuclear localization signals (NLS), PEST, and coiled-coil regions are also shown in overlines. Amino acid residues with conservation to the murine sequence are shaded Cdt1 as an oncogene E Arentson et al of 84 amino acids (84, 72, 67, 47 , and 43 amino acids, respectively) were identi®able, but none of the ORFs followed Kozak's consensus sequence, GCC(A or G)CCATGG, for the initiation of translation (Kozak, 1996) . Furthermore, the Ris1 region was highly divergent between human and mouse, although it is conserved between mouse and hamster (not shown). Therefore, we focused on Ris2/Cdt1 for subsequent studies. The expression of Ris2/Cdt1 was further analysed in human tissue samples. Ris2/Cdt1 expression was detectable in fetal tissues (Figure 3b ). Ris2/ Cdt1 was barely expressed in adult tissues except in bone marrow or thymus. Most importantly, Ris2/Cdt1 expression level was high in all tumor samples analysed ( Figure 3c ). Compared to a single mouse Ris2/Cdt1 gene transcript, human Ris2/Cdt1 showed two distinct transcripts, which represent the usage of two dierent poly(A)sites (not shown).
Oncogenic potential of Ris2/Cdt1
The ®ndings that Ris2/Cdt1 is activated by retroviral insertion, which coincided with EB-PE immortalization, and that it is overexpressed in many tumor cells suggested that Ris2/Cdt1 is an oncogene. (Shinkai et al., 1992) to determine if cells overexpressing Ris2/Cdt1 showed any growth advantage in vivo. Four out of 10 mice (from two independent experiments) that received NIH3T3/Ris2/ Cdt1 cells developed tumors by week 4 ± 5 (Table 1) . None of the mice developed tumors when injected with control NIH3T3 cells (n=10) or with NIH3T3 expressing the empty vector alone (MSCV, n=4). The ®nding that not all the mice developed tumors could re¯ect the heterogeneous nature of the pooled cell population that was used for the initial injection. Therefore, we generated subclones from the initial pooled population. Five independent subclones which showed higher levels of CDT1 protein compared to parental NIH3T3 cells ( Figure 4a ) were injected into rag2 7/7 mice to determine their ability to form tumors. All four subclones (3T3 Ris2/Cdt171, 5, 6, and 15) formed tumors by 5 ± 6 week in rag2 7/7 mice (n=3 each, total 12), while one (3T3 Ris2/Cdt1712) subclone formed a tumor in one out of three mice injected. None of the mice with the NIH3T3 cells with the empty vector alone formed tumors (n=4). These results strongly suggest that CDT1 can function as an oncogene. Subsequently, tumors were excised and donor cell origin was veri®ed by Southern blot analysis using the retroviral vector genome (not shown). When two independent cell lines were tested, six out of six and two out of three (one died) mice, respectively, developed tumors by 2 ± 3 weeks. It is important to note that the onset of the primary tumor formation was very slow, and yet the onset of secondary tumor development was rapid. Western blot analyses demonstrated that the CDT1 level was much higher in NIH3T3/Ris2/Cdt176 derived tumor cells compared to the parental NIH3T3/Ris2/Cdt176 cells, while NIH3T3/Ris2/Cdt171 derived tumor cells expressed similar levels of CDT1 compared to parental NIH3T3/ Ris2/Cdt171 cells (Figure 4b ).
RIS2/CDT1 in cell cycle regulation
To demonstrate that RIS2 is indeed a mouse homologue of CDT1, we performed cell cycle analysis with the expectation that cells overexpressing Ris2/ Cdt1 would readily undergo DNA replication. As the pool of NIH3T3/Ris2/Cdt1 cells over-expressing Ris2/ Cdt1 did not show any apparent faster doubling time (not shown), we tested subclones used for the tumor studies for early entry into the cell cycle after serum starvation. Cells were synchronized to G0/G1 phase by growing them in low serum (0.5%) for 72 h. By this time, 80 ± 90% of the cells in low serum were growth arrested at G0/G1 ( Figure 5) . A large percentage of the cells have progressed into S phase by the 9 h point in control NIH3T3 cells following serum stimulation (Figure 5a ). More importantly, NIH3T3 cells overexpressing Ris2/Cdt1 had a higher percentage of cells in the S phase 9 h after serum stimulation compared to controls. This was true for BrdU uptake (A) and propidium iodide staining (PI, B). None of the subclones from NIH3T3 cells (total 10) or NIH3T3 cells expressing MSCV (total 12) showed such cell cycle changes (Figure 6a , not shown). When NIH3T3/Ris2/ Cdt175, 76, and 715 were further analysed, the early entry into S phase was observed as early as 6 h after serum stimulation compared to NIH3T3 cells ( Figure  5b , not shown). CDT1 has been shown to be made in the G1 phase and degraded after the cells enter the S phase (Wohlschlegel et al., 2000; Nishitani et al., 2001) . Consistent with these ®ndings, CDT1 was present at low levels in serum starved NIH3T3 cells and was slightly increased 9 ± 12 h after serum stimulation (Figure 5b , not shown). Importantly, all the Ris2/ Cdt1 overexpressing clones, NIH3T3/Ris2/Cdt175, 76, and 715, showed higher levels of CDT1 even in serum starved cells (Figure 5b ). This could explain why the Ris2/Cdt1 overexpressing cells readily enter the S phase when stimulated with serum. Importantly, the exogenous CDT1 appears to undergo the same degradation as the endogenous CDT1 as shown by the lower level of CDT1 at later time points after serum stimulation (Figure 5b ). Together, our results strongly suggested that overexpression of Ris2/Cdt1 could promote quicker entry into S phase.
Discussion
Due to the randomness of retroviral DNA integration, retroviral insertion can often deregulate the¯anking cellular gene. This particular trait of the retroviral insertion has been the basis for isolating novel oncogenes (Nusse, 1991; Peters, 1990 Our studies demonstrated that NIH3T3 cells constitutively overexpressing Ris2/Cdt1 formed tumors in rag2 7/ 7 mice. NIH3T3 cells constitutively overexpressing Ris2/ Cdt1 quickly entered into S phase when released from serum starvation, although we did not observe any shorter doubling time (not shown). Clearly, NIH3T3 cells overexpressing Ris2/Cdt1 readily showed growth advantage in vivo than in vitro tissue culture system. It appears that even though Ris2/Cdt1 overexpression could shorten the G0/G1 phase in cultured cells, DNA rereplication requires additional molecule(s)/signal(s). Indeed, DNA re-replication in ®ssion yeast requires both CDT1 and CDC6 and CDT1 overexpression alone did not result in re-replication (Nishitani et al., 2000) . Further studies are necessary to understand the mechanism of oncogenic function of Ris2/Cdt1. Given the recent ®ndings that geminin, a negative regulator of DNA replication, targets CDT1 (Wohlschlegel et al., 2000; Lygerou and Nurse, 2000; Madine and Laskey, 2001; Tada et al., 2001) , it is possible that overexpression of Ris2/Cdt1 could override such a negative control, allowing cells to continuously replicate. In fact, excess CDT1 could negate the inhibition of DNA replication by geminin in Xenopus cell free replication system (Wohlschlegel et al., 2000) . Together, our studies are the ®rst to demonstrate that proteins involved in DNA replication can function as an oncogene.
Ris2/Cdt1 is located immediately downstream of the adenine phosphoribosyl transferase (Aprt) gene. Incidentally, human, as well as the hamster Aprt locus has been shown to be unstable and has been used as a model for the study of autosomal loss of heterozygosity (LOH, Phear et al., 1989; Zhu et al., 1993; Stambrook et al., 1996; Gupta et al., 1994; Wijnhoven et al., 1998; Van Sloun et al., 1998; Shao et al., 1999) . Missense, nonsense, and frame shift mutations in the coding region, or deletions of several amino acids frequently associate with the loss of APRT function. Large deletions eliminating the Aprt gene also occur, but large deletions in both human and Chinese hamster ovary (CHO) cells have been shown to be nonrandom. In CHO cells, the endpoints of the deletions were either upstream or *8.5 kb downstream of the Aprt gene (Dewyse and Bradley, 1989) . Likewise, deletions at the human Aprt locus always spared the immediate downstream sequence (Harwood and Meuth, 1995) . The investigators of these studies all speculated that the gene located directly downstream of the Aprt locus is important for cell survival. Now we show that this critical gene is Ris2/Cdt1.
Given the ®ndings that Ris2/Cdt1 is located close to Aprt and that the Aprt locus is unstable, it is tempting to speculate that the Ris2/Cdt1 locus is also unstable, as such spontaneous mutations occurring at the Aprt locus would also occur at the Ris2/Cdt1 locus. Cells that acquire mutations inactivating or eliminating Ris2/ Cdt1 would die. However, cells that acquire either activated Ris2/Cdt1 transcription or activating mutations of Ris2/Cdt1 could have growth advantage. In this regard, it is very intriguing to observe that all the tumor samples we examined so far overexpress Ris2/ Cdt1 (Figure 3) . Clearly, cells carrying mutations in cell cycle control components could gain a growth advantage over their normal cell counterparts (Hirama and Koeer, 1995) . Cyclin D1 is overexpressed in many cancers (Motokura et al., 1991) and INK4a is inactivated in familial melanoma, biliary tract, and esophageal carcinomas (Kamb et al., 1994; Nobori et al., 1994) . Direct inactivation of retinoblastoma (RB) protein is necessary for retinoblastoma development and adult small cell lung carcinoma (Knudson, 1971; Friend et al., 1986; Hall and Peters, 1996) . Our ®ndings provide yet another example that deregulation in DNA replication could result in abnormal cell growth.
Materials and methods
cDNA and genomic clone isolation
Full length Ris1 cDNA was obtained by screening a day 13.5 ± 14.5 mouse embryo cDNA library (Stratagene) with the 0.9 kb 
CDT1 monoclonal antibody generation
The murine CDT1 gene fragment encoding residues 177 to 557 was ampli®ed and cloned into an unmodi®ed pET15b vector (Novagen, Madison, WI, USA) for the expression in E. coli (pCDTZ). The gene product from this vector was designated CDT1D176. The E. coli expressed CDT1D176 was puri®ed as a 6HISTag fusion protein using a Ni column as a crude puri®cation step to separate the protein from the whole cell extract. The protein eluting from the Ni column was shown by SDS ± PAGE analysis to contain several contaminating bands. The protein was subsequently puri®ed to homogeneity taking advantage of its high isoelectric point (pI &9.6) and using a cation exchange MonoS column (Amersham Pharmacia Biotech, Piscataway, NJ, USA). The puri®ed protein was veri®ed by electro-spray ionization (ESI) mass spectrometry to be within +1 mass unit of the theoretically predicted mass (45 083 daltons). The ESI experiments were carried out at The HHMI Biopolymer/ Keck Foundation Biotechnology Resource Laboratory at Yale University Medical School. Armenian hamsters were immunized with 100 mg of puri®ed CDT1D176, a total of three times at 2 week intervals. After the ®nal boost, the spleen was harvested and fused with the myeloma cell line Ag8 to generate hybridomas. The fusion was carried out by the hybridoma center at Washington University. Positive hybridomas were identi®ed by ELISA analyses by using CDT1D176. Monoclonal CDT1 antibody was further puri®ed with protein A sepharose.
Western blot analysis
Total cell extracts were prepared from NIH3T3 or NIH3T3/ Ris2/Cdt1 cells by sonication. The protein amount was measured by Bio-Rad protein assay kit. Twenty mg of protein was analysed on a 7.5% or 10% SDS ± PAGE gel. Proteins were transferred to a PVDF (Amersham) and incubated with a mouse monoclonal antibody against CDT1 or with antiactin antibody (Santa Cruz). Horseradish-peroxidase-conjugated anti-armenian hamster IgG (Jackson Immuno Research, CDT1) or horseradish-peroxidase-conjugated anti goat IgG antibody (Sigma, Actin) was used as a secondary antibody. The protein complex was detected by the ECL-plus detection system (Amersham) or Super Signal West Femto (Pierce).
Tumor formation
NIH3T3 or the respective clones were trypsinized, washed twice with PBS, counted and set at a ®nal cell density of 12610 6 cells per milliliter. Each mouse received 3610 6 cells subcutaneously using a 25-gauge needle. Animals were monitored on a regular basis for tumor formation (up to 5 ± 6 weeks). Animals were sacri®ced when the tumor burden became too large.
Tumor cell line establishment
Tumors were excised using forceps and scissors. The tumor mass was treated with Collagenase type 1A (0.25% in PBS+10% FCS) for 90 min. Following digestion, cells were passed through a 20 gauge needle and plated onto gelatinized tissue culture plates with 10% fetal calf serum (FCS) in IMDM media.
Cell cycle analysis
Cells were trypsinized, centrifuged, resuspended in 250 ml PBS, ®xed in 1 ml 70% ethanol containing 50 mM Glycine, and stored at 7208C for at least 20 min. For propidium iodide (PI) staining, cells were spun and resuspended in 250 ml PBS and then an equal volume of 1% NP-40/30 mg/ml propidium iodide (Molecular Probes, Eugene, OR, USA)/ 1 mg/ml Aprotinin, 1 mg/ml Leupeptin and 50 mg/ml PMSF (Sigma, St. Louis, MO, USA). Before analysis using a Becton-Dickinson FACS Caliber ow cytometer, cells were ®ltered through 40 micron nylon mesh. Cells were plotted and gated to exclude cell aggregates. Data were analysed using CellQuest software (Becton-Dickinson). For BrdU analysis, cells were pulsed while in culture with 10 mm BrdU (Amersham) for various lengths of time. Cells were trypsinized, rinsed in PBS, resuspended in 250 ml PBS plus 1 ml of 70% ethanol/50 mM glycine, and stored for at least 20 min at 7208C. Cells were spun and resuspended in 1 ml of denaturing solution (2 M HCl/0.5% BSA/0.5% NP-40) and rocked slowly for 45 min at room temperature. After pelleting, cells were resuspended in 1 ml neutralizing solution (0.1 M sodium borate, pH 8.5) and rocked at room temperature for 5 min. Again cells were pelleted and resuspended in 50 ml dilution buer (PBS/0.5% Tween-20/0.5% FCS). One ml of anti-BrdU antibody (Caltag, MD, USA) was added and cells incubated in the dark at room temperature for 30 min. Control samples using a control IgG isotype were also prepared. One ml of dilution buer was added to rinse followed by centrifugation. Cells were rinsed a total of three times. Finally, cells were resuspended in 500 ml Propidium Iodide solution (20 ug/ml PI, 1% FCS) and analysed with a Becton-Dickinson FACSCaliber ow cytometer.
